# Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma

> **NCT01638572** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 90 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01638572
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2012-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638572, "Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01638572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*